vs

Side-by-side financial comparison of OCULAR THERAPEUTIX, INC (OCUL) and Soluna Holdings, Inc (SLNH). Click either name above to swap in a different company.

OCULAR THERAPEUTIX, INC is the larger business by last-quarter revenue ($13.3M vs $8.4M, roughly 1.6× Soluna Holdings, Inc). Soluna Holdings, Inc runs the higher net margin — -284.7% vs -488.0%, a 203.3% gap on every dollar of revenue. On growth, Soluna Holdings, Inc posted the faster year-over-year revenue change (11.8% vs -22.4%). Soluna Holdings, Inc produced more free cash flow last quarter ($-6.8M vs $-57.1M). Over the past eight quarters, OCULAR THERAPEUTIX, INC's revenue compounded faster (-5.3% CAGR vs -8.8%).

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

OCUL vs SLNH — Head-to-Head

Bigger by revenue
OCUL
OCUL
1.6× larger
OCUL
$13.3M
$8.4M
SLNH
Growing faster (revenue YoY)
SLNH
SLNH
+34.3% gap
SLNH
11.8%
-22.4%
OCUL
Higher net margin
SLNH
SLNH
203.3% more per $
SLNH
-284.7%
-488.0%
OCUL
More free cash flow
SLNH
SLNH
$50.2M more FCF
SLNH
$-6.8M
$-57.1M
OCUL
Faster 2-yr revenue CAGR
OCUL
OCUL
Annualised
OCUL
-5.3%
-8.8%
SLNH

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
OCUL
OCUL
SLNH
SLNH
Revenue
$13.3M
$8.4M
Net Profit
$-64.7M
$-24.0M
Gross Margin
88.0%
9.5%
Operating Margin
-526.5%
-92.5%
Net Margin
-488.0%
-284.7%
Revenue YoY
-22.4%
11.8%
Net Profit YoY
-33.6%
-233.2%
EPS (diluted)
$-0.27
$-1.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OCUL
OCUL
SLNH
SLNH
Q4 25
$13.3M
Q3 25
$14.5M
$8.4M
Q2 25
$13.5M
$6.2M
Q1 25
$10.7M
$5.9M
Q4 24
$17.1M
$8.3M
Q3 24
$15.4M
$7.5M
Q2 24
$16.4M
$9.7M
Q1 24
$14.8M
$12.5M
Net Profit
OCUL
OCUL
SLNH
SLNH
Q4 25
$-64.7M
Q3 25
$-69.4M
$-24.0M
Q2 25
$-67.8M
$-7.4M
Q1 25
$-64.1M
$-7.6M
Q4 24
$-48.4M
$-40.0M
Q3 24
$-36.5M
$-7.2M
Q2 24
$-43.8M
$-10.9M
Q1 24
$-64.8M
$-5.3M
Gross Margin
OCUL
OCUL
SLNH
SLNH
Q4 25
88.0%
Q3 25
87.8%
9.5%
Q2 25
85.6%
6.3%
Q1 25
88.2%
5.7%
Q4 24
92.8%
-360.8%
Q3 24
89.9%
-39.1%
Q2 24
90.8%
34.6%
Q1 24
91.0%
45.4%
Operating Margin
OCUL
OCUL
SLNH
SLNH
Q4 25
-526.5%
Q3 25
-472.3%
-92.5%
Q2 25
-502.6%
-107.6%
Q1 25
-597.5%
-120.9%
Q4 24
-296.1%
-426.0%
Q3 24
-298.2%
-119.8%
Q2 24
-265.1%
-38.0%
Q1 24
-214.0%
3.2%
Net Margin
OCUL
OCUL
SLNH
SLNH
Q4 25
-488.0%
Q3 25
-477.3%
-284.7%
Q2 25
-503.9%
-119.9%
Q1 25
-598.7%
-127.3%
Q4 24
-283.3%
-483.8%
Q3 24
-236.6%
-95.5%
Q2 24
-266.3%
-112.4%
Q1 24
-438.9%
-41.9%
EPS (diluted)
OCUL
OCUL
SLNH
SLNH
Q4 25
$-0.27
Q3 25
$-0.38
$-1.14
Q2 25
$-0.39
$-0.93
Q1 25
$-0.38
$-1.21
Q4 24
$-0.25
$-7.14
Q3 24
$-0.22
$-1.56
Q2 24
$-0.26
$-3.62
Q1 24
$-0.49
$-2.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OCUL
OCUL
SLNH
SLNH
Cash + ST InvestmentsLiquidity on hand
$737.1M
Total DebtLower is stronger
$13.3M
Stockholders' EquityBook value
$654.3M
$14.5M
Total Assets
$808.1M
$152.0M
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OCUL
OCUL
SLNH
SLNH
Q4 25
$737.1M
Q3 25
$344.8M
Q2 25
$391.1M
Q1 25
$349.7M
Q4 24
$392.1M
Q3 24
$427.2M
Q2 24
$459.7M
Q1 24
$482.9M
Total Debt
OCUL
OCUL
SLNH
SLNH
Q4 25
Q3 25
$13.3M
Q2 25
$10.0M
Q1 25
$10.2M
Q4 24
$7.1M
Q3 24
$8.1M
Q2 24
$9.0M
Q1 24
Stockholders' Equity
OCUL
OCUL
SLNH
SLNH
Q4 25
$654.3M
Q3 25
$258.2M
$14.5M
Q2 25
$305.9M
$-19.5M
Q1 25
$265.9M
$-16.1M
Q4 24
$315.3M
$-12.5M
Q3 24
$352.0M
$20.9M
Q2 24
$377.7M
$24.4M
Q1 24
$408.0M
$21.5M
Total Assets
OCUL
OCUL
SLNH
SLNH
Q4 25
$808.1M
Q3 25
$410.9M
$152.0M
Q2 25
$451.3M
$92.0M
Q1 25
$405.9M
$90.0M
Q4 24
$457.9M
$88.0M
Q3 24
$490.4M
$97.3M
Q2 24
$517.1M
$98.7M
Q1 24
$538.9M
$90.6M
Debt / Equity
OCUL
OCUL
SLNH
SLNH
Q4 25
Q3 25
0.92×
Q2 25
Q1 25
Q4 24
Q3 24
0.39×
Q2 24
0.37×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OCUL
OCUL
SLNH
SLNH
Operating Cash FlowLast quarter
$-54.2M
$-2.2M
Free Cash FlowOCF − Capex
$-57.1M
$-6.8M
FCF MarginFCF / Revenue
-430.9%
-81.4%
Capex IntensityCapex / Revenue
21.4%
55.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-216.9M
$-34.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OCUL
OCUL
SLNH
SLNH
Q4 25
$-54.2M
Q3 25
$-50.7M
$-2.2M
Q2 25
$-55.2M
$-1.1M
Q1 25
$-44.7M
$-177.0K
Q4 24
$-39.4M
$-5.1M
Q3 24
$-36.6M
$61.0K
Q2 24
$-24.8M
$-7.3M
Q1 24
$-33.9M
$3.9M
Free Cash Flow
OCUL
OCUL
SLNH
SLNH
Q4 25
$-57.1M
Q3 25
$-56.7M
$-6.8M
Q2 25
$-56.5M
$-9.7M
Q1 25
$-46.6M
$-4.0M
Q4 24
$-39.6M
$-13.9M
Q3 24
$-36.6M
$-3.4M
Q2 24
$-25.5M
$-7.6M
Q1 24
$-34.1M
$3.3M
FCF Margin
OCUL
OCUL
SLNH
SLNH
Q4 25
-430.9%
Q3 25
-390.0%
-81.4%
Q2 25
-419.7%
-156.8%
Q1 25
-435.6%
-67.1%
Q4 24
-232.0%
-168.3%
Q3 24
-237.6%
-44.8%
Q2 24
-155.4%
-78.2%
Q1 24
-231.1%
26.5%
Capex Intensity
OCUL
OCUL
SLNH
SLNH
Q4 25
21.4%
Q3 25
41.2%
55.2%
Q2 25
9.3%
139.0%
Q1 25
18.1%
64.2%
Q4 24
1.2%
107.0%
Q3 24
0.6%
45.6%
Q2 24
4.5%
2.5%
Q1 24
1.7%
4.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OCUL
OCUL

Segment breakdown not available.

SLNH
SLNH

Data Hosting Revenue$5.3M62%
Cryptocurrency Mining Revenue$2.8M33%
Other$389.0K5%

Related Comparisons